Recurrence characteristics in European patients with ocular toxoplasmosis

British Journal of Ophthalmology

Volumn 92, Issue 9, 2008, Pages 1253-1256

  Garweg, J G ^a,b   Scherrer, J N ^c   Halberstadt, M ^a,d  

^a Swiss Eye Institute   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^d HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; DISEASE ACTIVITY; DISEASE COURSE; EUROPEAN AMERICAN; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; QUESTIONNAIRE; RECURRENT DISEASE; RETROSPECTIVE STUDY; TOXOPLASMOSIS;

ADULT; AGE DISTRIBUTION; AGE FACTORS; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIPARASITIC AGENTS; DISEASE PROGRESSION; EPIDEMIOLOGIC METHODS; EUROPE; FEMALE; HUMANS; MALE; RECURRENCE; TOXOPLASMA; TOXOPLASMOSIS, OCULAR; TREATMENT OUTCOME;

EID: 47249156293     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2007.123661     Document Type: Article

References (35)

1. Gilbert RE, Dunn DT, Lightman S, et al. Incidence of symptomatic Toxoplasma eye disease: aetiology and public health implications. Epidemiol Infect 1999;123:283-9.
2. Silveira C, Belfort R Jr, Muccioli C, et al. A follow-up study of Toxoplasma gondii infection in southern Brazil. Am J Ophthalmol 2001;131:351-4.
3. Silveira C, Belfort R Jr, Muccioli C, et al. The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. Am J Ophthalmol 2002;134:41-6.
4. de Amorim Garcia CA, Orefice F, de Oliveira Lyra C, et al. Socioeconomic conditions as determining factors in the prevalence of systemic and ocular toxoplasmosis in Northeastern Brazil. Ophthalmic Epidemiol 2004;11:301-17.
5. Bosch-Driessen LE, Berendschot TT, Ongkosuwito JV, et al. Ocular toxoplasmosis: clinical features and prognosis of 154 patients. Ophthalmology 2002;109:869-78.
6. Hovakimyan A, Cunningham ET Jr. Ocular toxoplasmosis. Ophthalmol Clin North Am 2002;15:327-32.
7. Bosch-Driessen EH, Rothova A. Recurrent ocular disease in postnatally acquired toxoplasmosis. Am J Ophthalmol 1999;128:421- 5.
8. O'Connor GR. Factors related to the initiation and recurrence of uveitis: XL Edward Jackson Memorial Lecture. Am J Ophthalmol 1983;96:577-99.
9. Bosch-Driessen LH, Plaisier MB, Stilma JS, et al. Reactivations of ocular toxoplasmosis after cataract extraction. Ophthalmology 2002;109:41-5.
10. Garweg JG, Scherrer J, Wallon M, et al. Reactivation of ocular toxoplasmosis during pregnancy. Br J Obstet Gynaecol 2005;112:241-2.
11. Holland GN, Engstrom RE Jr, Glasgow BJ, et al. Ocular toxoplasmosis in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol 1988;106:653-67.
12. Holland GN, O'Connor GR, Diaz RF, et al. Ocular toxoplasmosis in immunosuppressed nonhuman primates. Invest Ophthalmol Vis Sci 1988;29:835-42.
13. Holland GN. Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management. Am J Ophthalmol 2004;137:1-17.
14. Johnson MW, Greven GM, Jaffe GJ, et al. Atypical, severe toxoplasmic retinochoroiditis in elderly patients. Ophthalmology 1997;104:48-57.
15. Jones JL, Muccioli C, Belfort R Jr, et al. Recently acquired Toxoplasma gondii infection. Brazil Emerg Infect Dis 2006;12:582-7.
16. Labalette P, Delhaes L, Margaron F, et al. Ocular toxoplasmosis after the fifth decade. Am J Ophthalmol 2002;133:506-15.
17. Morhun PJ, Weisz JM, Elias SJ, et al. Recurrent ocular toxoplasmosis in patients treated with systemic corticosteroids. Retina 1996;16:383-7.
18. Friedmann CT, Knox D. Variations in recurrent active toxoplasmic retinochoroiditis. Arch Ophthalmol 1969;81:481-93.
19. Rothova A. Ocular manifestations of toxoplasmosis. Curr Opin Ophthalmol 2003;14:384-8.
20. Glasner PD, Silveira C, Kruszon-Moran D, et al. An unusually high prevalence of ocular toxoplasmosis in southern Brazil. Am J Ophthalmol 1992;114:136-44.
21. Silveira C, Belfort R Jr, Burnier M Jr, et al. Acquired toxoplasmic infection as the cause of toxoplasmic retinochoroiditis in families. Am J Ophthalmol 1988;106:362-4.
22. Lum F, Jones JL, Holland GN, et al. Survey of ophthalmologists about ocular toxoplasmosis. Am J Ophthalmol 2005;140:724-6.
23. Holland GN. Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease. Am J Ophthalmol 2003;136:973- 88.
24. Holland GN. Reconsidering the pathogenesis of ocular toxoplasmosis. Am J Ophthalmol 1999;128:502-5.
25. Jones JL, Kruszon-Moran D, Wilson M, et al. Toxoplasma gondii infection in the United States: Seroprevalence and risk factors, Am J Epidemiol 2001;154:357-65.
26. Joynson DH. Epidemiology of toxoplasmosis in the U.K. Scand J Infect Dis 1992;84(Suppl):65-9S.
27. Portela RW, Bethony J, Costa Ml, et al. A multihousehold study reveals a positive correlation between age, severity of ocular toxoplasmosis, and levels of glycoinositolphospholipid-specific immunoglobulin A. J Infect Dis 2004;190:175-83.
28. Gilbert R, Tan HK, Cliffe S, et al. Symptomatic Toxoplasma infection due to congenital and postnatally acquired infection. Arch Dis Child 2006;91:495-8.
29. Smith KL, Wilson M, Hightower AW, et al. Prevalence of Toxoplasma gondii antibodies in US military recruits in 1989: Comparison with data published in 1965. Clin Infect Dis 1996;23:1182-3.
30. Jones LA, Alexander J, Roberts CW. Ocular toxoplasmosis: in the storm of the eye. Parasite Immunol 2006;28:635-42.
31. Garweg JG, Jacquier P, Böhnke M. Early aqueous humor analysis in patients with human ocular toxoplasmosis. J Clin Microbiol 2000;38:996-1001.
32. Garweg JG, Boehnke M. The antibody response in experimental ocular toxoplasmosis. Graefes Arch Clin Exp Ophthalmol 2006;244:1668-79.
33. Garweg JG. Determinants of immunodiagnostic success in human ocular toxoplasmosis. Parasite Immunol 2005;27:61-8.
34. Stanford MR, See SE, Jones LV, et al. Antibiotics for toxoplasmic retinochoroiditis: an evidence-based systematic review. Ophthalmology 2003;110:926-31.
35. Scherrer J, lliev ME, Halberstadt M, et al. Visual function in human ocular toxoplasmosis. Br J Ophthalmol 2007;91:233-6.